Annual report pursuant to Section 13 and 15(d)

Consolidated Statements Of Operations And Comprehensive Loss

v3.22.0.1
Consolidated Statements Of Operations And Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]      
Net revenue $ 39,188 $ 22,780 $ 37,799
Cost of revenue 22,659 16,607 23,511
Gross profit 16,529 6,173 14,288
Operating expenses:      
Sales and marketing 15,339 11,242 14,396
General and administrative 11,258 9,772 10,748
Engineering and development 6,048 3,695 4,765
Loss on patent litigation settlement 315
Total operating expenses 32,960 24,709 29,909
Loss from operations (16,431) (18,536) (15,621)
Loss on foreign currency transactions (452) (21) (121)
Interest expense, net (2,224) (2,359) (2,157)
Gain on debt forgiveness 3,014
Other income, net 4,215
Non-operating gain (loss), net 338 1,835 (2,278)
Loss before income tax provision (16,093) (16,701) (17,899)
Income tax (provision) benefit (65) (128) 44
Net loss (16,158) (16,829) (17,855)
Other comprehensive loss items:      
Foreign currency translation adjustments (238) 316 (31)
Comprehensive loss (16,396) (16,513) (17,886)
Net loss (16,158) (16,829) (17,855)
Deemed dividend on convertible preferred stock (546) (17,378)
Net loss attributable to common stockholders $ (16,704) $ (34,207) $ (17,855)
Net loss per share attributable to common stockholders:      
Basic and Diluted $ (0.11) $ (0.56) $ (0.77)
Shares used in the calculation of net loss per share:      
Basic and Diluted 147,746 61,136 23,201